Medullary Thyroid Cancer: Overview and Case Study of a Rare Cancer
Medullary thyroid cancer (MTC) is a rare cancer that has historically been managed by endocrinologists. In 2011, the first of several multi- targeted tyrosine kinase inhibitors was approved as treatment for MTC. These drugs have changed the management of MTC to teams that include oncologists and oncology nurses. This article illustrates MTC diagnostics, surveillance, management of adverse drug reactions, and disease progression through a case study. An overview of MTC is offered, followed by an in-depth case study that examines MTC from the patient's perspective. Oncology nurses can influence patient outcomes through the provision of patient education, support, and management of disease and treatment complications.